Iofina Regulatory News (IOF)

16 December 2014

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

BOARD CHANGE

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, announces the resignation of Mr. Jeffery Ploen from the Board of Directors with immediate effect.

Mr Ploen had indicated earlier in the year that he may choose to resign from the Board to focus on his other commitments, and as such the process of identifying a suitable replacement is already underway.Commenting, President and CEO Dr. Tom Becker said: "On behalf of all the team we thank Jeff for his years of service and underlying support as a shareholder. We wish him well."

For further information, please contact:

Dr. Tom Becker, CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

John Prior/Rupert Krefting/Paul Gillam

Numis Securities

Tel: +44 (0)20 7260 1000

Rob Collins/Emily Morris/Liz Williamson

GMP Securities

Tel: +44(0)20 7647 2800

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR

Tel: +44 (0)7768 537 739

About Iofina:

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives and produced water. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb® technology. Iofina has production operations in the United States, specifically in Texas, Montana, Kentucky and Oklahoma. It has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end-products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. Iofina utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

www.iofina.com